ASTROCYTOMA, GRADE III

Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.

Never miss a new study

Get alerted when new ASTROCYTOMA, GRADE III trials appear

Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New hope for fighting aggressive brain tumors

Disease control Recruiting now

This study is testing a new drug called Debio 0123 for adults with glioblastoma, a fast-growing brain cancer. The goal is to see if adding this drug to standard chemotherapy (temozolomide) and radiation is safe and can help control the cancer better. The research will first find …

Matched conditions: ASTROCYTOMA, GRADE III

Phase: PHASE1, PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ASTROCYTOMA, GRADE III

Get alerted when new ASTROCYTOMA, GRADE III trials appear

New hope for fighting aggressive brain tumors